Posted inAntitrust Laws and Competition Issues Content Type: Service Drugs (Pharmaceuticals) Federal Trade Commission Generic Brands and Products GlaxoSmithKline PLC Inventions and Patents Regulation and Deregulation of Industry
Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says
Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.